- Home
- SLGB vs NTRB Comparison
SLGB vs NTRB Comparison
Compare SLGB & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGB | NTRB |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.2M | 71.7M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLGB | NTRB |
|---|---|---|
| Price | $1.91 | $4.93 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 43.0K | 20.3K |
| Earning Date | 12-23-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $92,917,774.00 | $2,578,059.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $65.13 | ★ N/A |
| Revenue Growth | N/A | ★ 42.92 |
| 52 Week Low | $1.74 | $3.72 |
| 52 Week High | $6.08 | $11.78 |
Technical Indicators
Market Signals| Indicator | SLGB | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.25 |
| Support Level | N/A | $4.45 |
| Resistance Level | N/A | $5.25 |
| Average True Range (ATR) | 0.00 | 0.33 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 51.61 |
Price Performance
Historical ComparisonAbout SLGB Smart Logistics Global Limited Ordinary Shares
Smart Logistics Global Ltd is a contract logistics solution provider in the PRC focusing on industrial raw materials line-haul transportation business. the group focuses on the logistics digital ecosystem through innovation, digital analytics, and infrastructure establishment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.